Research Funding

  • Harnessing Data Science for Health Discovery and Innovation in Africa

 

High-Risk Research: NIH Director's Early Independence Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
NIH Directors Early Independence Awards (DP5 Clinical Trial Optional) 4/27/2022 RFA-RM-22-021 Becky Miller
earlyindependence@mail.nih.gov
301-594-9979
Letter of Intent:
8/2/2022
Receipt Date:
9/2/2022
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 11/16/2020 PA-21-071 Becky Miller
earlyindependence@mail.nih.gov
301-594-9979
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Becky Miller
earlyindependence@mail.nih.gov
301-594-9979
 

High-Risk Research: NIH Director's New Innovator Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
NIH Director’s New Innovator Award Program (DP2 Clinical Trial Optional) 4/7/2022 RFA-RM-22-019 Patricia (Trish) Labosky

NewInnovatorAwards@mail.nih.gov

301-594-4863
Receipt date:
8/19/2022
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 11/16/2020 PA-21-071 Ravi Basavappa
NewInnovatorAward@mail.nih.gov
(301) 435-7204
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Ravi Basavappa
NewInnovatorAward@mail.nih.gov
301 435-7204
 


High-Risk Research: NIH Director's Pioneer Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
2023 NIH Director’s Pioneer Award Program (DP1 Clinical Trial Optional) 4/13/2022 RFA-RM-22-018 Ravi Basavappa
PioneerAwards@mail.nih.gov
(301) 435-7204
9/9/2022
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 11/16/2020 PA-21-071 Ravi Basavappa
PioneerAwards@mail.nih.gov
(301) 435-7204
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Ravi Basavappa
PioneerAwards@mail.nih.gov
301 435-7204
 


High-Risk Research: NIH Director's Transformative Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
NIH Directors Transformative Research Awards (R01 Clinical Trial Optional) 5/12/2022 RFA-RM-22-020 Ravi Basavappa
Transformative_Awards@mail.nih.gov (link sends e-mail)
(301) 435-7204
9/1/2022
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 11/16/2020 PA-21-071 Ravi Basavappa
Transformative_Awards@mail.nih.gov
(301) 435-7204
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Ravi Basavappa
Transformative_Awards@mail.nih.gov
(301) 435-7204
 

Illuminating the Druggable Genome Program

Title NIH Guide RFA Number Common Fund Contact Estimated
Receipt Date
Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) 4/15/2022 RFA-RM-22-024 Karlie Sharma
DruggableGenome@mail.nih.gov
301-451-4965
Letter of Intent:
6/15/2022
Receipt Date:
7/15/2022

Somatic Cell Genome Editing (SCGE) Program

Title NIH Guide RFA Number NIH Contact Receipt Date
Somatic Cell Genome Editing Translational Coordination and Dissemination Center (U24, Clinical Trial Not Allowed) 4/11/2022 RFA-RM-22-017 Marrah Lachowicz-Scroggins
marrah.lachowicz-scroggins@nih.gov
301-827-8229
Letter of Intent:
6/17/2022
Application Receipt Date:
7/19/2022
Platform Clinical Trials of Somatic Genome Editing for Multiple Diseases (UG3/UH3, Clinical Trial Required) 4/11/2022 RFA-RM-22-016 P.J. Brooks
pj.brooks@mail.nih.gov
301-443-0513
Letter of Intent:
6/17/2022
Application Receipt Date:
7/19/2022

IND-enabling Studies of Somatic Genome Editing Therapeutic Leads (U19, Clinical Trial Not allowed)

4/11/2022 RFA-RM-22-015 Chris Boshoff
chris.boshoff@nih.gov
301-496-1779
Letter of Intent:
6/17/2022
Application Receipt Date:
7/19/2022
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed) 4/11/2022 RFA-RM-22-014 Betty Poon
poonb@mail.nih.gov
240-669-5024
Letter of Intent:
6/17/2022
Application Receipt Date:
7/19/2022

Somatic Mosaicism across Human Tissues (SMaHT)

Title NIH Guide RFA Number NIH Contact Estimated Receipt Date
Somatic Mosaicism across Human Tissues (SMaHT) Program: Organizational Center (U24 Clinical Trial Not Allowed) 2/23/2022 RFA-RM-22-009
Jill A. Morris
SMaHT@mail.nih.gov
301-496-5745
Letters of Intent:
06/08/2022
Receipt Date:
07/08/2022

 
Somatic Mosaicism across Human Tissues (SMaHT) Program: Data Analysis Center (UM1 Clinical Trial Not Allowed) 2/23/2022 RFA-RM-22-010 Amy C. Lossie
SMaHT@mail.nih.gov
301-827-6092
Letter of Intent:
06/08/2022
Receipt Date:
07/08/2022
Somatic Mosaicism across Human Tissues (SMaHT) Program: Tool Development Projects (UG3/UH3 Clinical Trial Not Allowed) 2/23/2022 RFA-RM-22-011 Jill Morris
SMaHT@mail.nih.gov
301-496-5754
Letter of Intent:
06/08/2022
Receipt Date:
07/08/2022
Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (U24 Clinical Trial Not Allowed) 2/23/2022 RFA-RM-22-012 Geetha Senthil
SMaHT@mail.nih.gov
301-402-0754
Letter of Intent:
06/08/2022
Receipt Date:
07/08/2022
Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed) 2/23/2022 RFA-RM-22-013 Amy C. Lossie
SMaHT@mail.nih.gov
301-827-6092
Letter of Intent:
06/08/2022
Receipt Date:
07/08/2022

NIH Faculty Institutional Recruitment for Sustainable Transformation

Title NIH Guide RFA Number NIH Contact Estimated Receipt Date

NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional)

 

02/17/2022 RFA-RM-22-008 Jessica M. Calzola
FIRSTNIH@nih.gov
240-276-7474

Letter of Intent
30 days prior to the application due date

Receipt Date:
07/12/2022

Harnessing Data Science for Health Discovery and Innovation in Africa

Title NIH Guide RFA Number Common Fund Contact Estimated
Receipt Date

Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa): Partnership for Innovation Research Projects (U01 Clinical Trial Not Allowed)

5/27/2022 RFA-RM-22-023 Brad Newsome
DS-IU01Mailbox@mail.nih.gov
301-451-1390
Letter of Intent:
8/29/2022
Receipt Dates:
9/28/2022
AIDS: 12/6/2022
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa): Research Education Program (UE5 Clinical Trial Not Allowed) 5/27/2022 RFA-RM-22-022 Laura Povlich
DS-IAfricaUE5@mail.nih.gov
301 827-2227
Letter of Intent:
8/29/2022
Receipt Dates:
9/28/2022

Past Funding Opportunities

 

 

This page last reviewed on June 15, 2022